Robust Guidelines for the Management of HR+ Her2- EBC: Crucial Value of CanAssist Breast.

Vaid, Ashok; T, Raja; Batra, Ullas; Krishna, Vamshi Muddu; Rangrajan, Bharath; Narayanan, Prasad; Vora, Amish; Advani, Suresh H

Vaid, Ashok; T, Raja; Batra, Ullas; Krishna, Vamshi Muddu; Rangrajan, Bharath; Narayanan, Prasad; Vora, Amish; Advani, Suresh H.

Afiliação

Vaid A; Department of Medical & HematoOncology, Cancer Institute, Medanta Hospital, Gurugram, Haryana, India.
T R; Department of Medical Oncology & BMT, Apollo Hospital, Chennai, Tamil Nadu, India.
Batra U; Department of Medical Oncology, Rajiv Gandhi Cancer Institute, New Delhi, India.
Krishna VM; Department of Medical Oncology, AIG Hospital, Hyderabad, Telangana, India.
Rangrajan B; Department of Medical Oncology, Kovai Medical Center and Hospital, Coimbatore, Tamil Nadu, India.
Narayanan P; Department of Medical Oncology, Hemato Oncology and BMT, Cytecare Hospital, Bengaluru, Karnataka, India.
Vora A; Department of Medical Oncology, Hope Cancer Clinic, New Delhi, India.
Advani SH; Smita Memorial Hospital & Research Center, Thodupuza, Kerala, India.

South Asian J Cancer ; 11(2): 95-96, 2022 Apr.

Article em En | MEDLINE | ID: mdl-36466976

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline Idioma: En Revista: South Asian J Cancer Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Índia

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google